REPLY:
Laure Elkrief, Marie Lazareth, Pierre‐Emmanuel Rautou – 26 April 2021
Impact of COVID‐19 Response on Hepatitis Prevention Care and Treatment: Results From Global Survey of Providers and Program Managers
Jessica Laury, Lindsey Hiebert, John W. Ward – 26 April 2021
Assessment of Noninvasive Markers of Liver Fibrosis in Patients With Chronic Hepatitis C in Ethiopia
Hailemichael Desalegn, Yemisrach Chanie, Paulos Shume, Miftah Delil, Neil Gupta, Asgeir Johannessen – 26 April 2021
Hepatitis C Care and Elimination in Ahtahkakoop Cree Nation: An Indigenous Community‐Led Model
Mamata Pandey, Noreen Reed, Stephanie Konrad, Trisha Campbell, Britin Cote, Tanys Isbister, Vanessa Ahenakew, Patricia Isbister, Jodie Albert, Stuart Skinner – 26 April 2021
Living Donor Liver Transplantation: Is Recipient Age a Barrier?
Samir Abu‐Gazala, Peter L. Abt – 26 April 2021
The 6‐Minute Walk Test Distance Predicts Mortality in Cirrhosis: A Cohort of 694 Patients Awaiting Liver Transplantation
ThucNhi T. Dang, Maryam Ebadi, Juan G. Abraldes, Jennifer Holman, Jon Ashmead, Aldo J. Montano‐Loza, Puneeta Tandon – 26 April 2021
Low Molecular Weight Heparin in Liver Transplant Recipients After Sleeve Gastrectomy
- Read more about Low Molecular Weight Heparin in Liver Transplant Recipients After Sleeve Gastrectomy
Antonio Iannelli, Niccolo’ Petrucciani – 26 April 2021
Hepatitis C Care and Elimination in Ahtahkakoop Cree Nation: An Indigenous Community‐Led Model
Mamata Pandey, Noreen Reed, Stephanie Konrad, Trisha Campbell, Britin Cote, Tanys Isbister, Vanessa Ahenakew, Patricia Isbister, Jodie Albert, Stuart Skinner – 26 April 2021
Functional Characterization of Organoids Derived From Irreversibly Damaged Liver of Patients With NASH
Sarah McCarron, Brooke Bathon, Donna M. Conlon, Deepti Abbey, Daniel J. Rader, Katerina Gawronski, Christopher D. Brown, Kim M. Olthoff, Abraham Shaked, Tobias D. Raabe – 25 April 2021
The Importance of Glycemic Equipoise in NASH
Alina M. Allen, Brent A. Neuschwander‐Tetri – 25 April 2021